2m 2m 2m 2m 2m 2m 2m
ZENAS BIOPHARMA (ZBIO)
NASDAQ
$31.46+$0.02 (+0.06%)
Price as of Aug 03, 2026 4:00 AM EDT- $2.0BMarket Cap
- 104.02%1-Year Change
- BiotechnologyIndustry
ZENAS BIOPHARMA (ZBIO)
$31.46+$0.02 (+0.06%)
ZBIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $31.44 | ||
Change | -$0.83 (-2.57%) | ||
Open | $32.69 | ||
High | $32.95 | ||
Low | $30.60 | ||
Previous Close | $32.27 | ||
Volume | 452,231 | ||
30-Day Average Volume | 912,578 | ||
1-Week Change | 3.46% | ||
1-Month Change | 23.88% | ||
1-Year Change | 104.02% | ||
3-Year Change | 213.76% | ||
5-Year Change | 213.76% | ||
Fundamentals | |||
Shares Outstanding | 63.1M | ||
Total Assets | $747.7M | ||
Market Cap | $2.0B | ||
Enterprise Value | $1.8B | ||
Period: QTR TTM FY | |||
Revenue | $10.0M | ||
Net Income | -$81.0M | ||
Free Cash Flow | -$75.2M | ||
EBIT | -$80.8M | ||
EBITDA | -$80.8M | ||
Net Working Capital | $669.0M | ||
EPS | -$1.46 | ||
Enterprise Value/EBITDA | -22 | ||
Enterprise Value/Revenue | 175 | ||
P/B | 6 | ||
P/E | -22 | ||
PEG | -0 | ||
Price/Free Cash Flow | -26 | ||
Price/Operating Cash Flow | -26 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 12/24/2019 | ||
Last Split Factor | 1 : 2 | ||
Last Split Date | 05/24/2018 | ||
Earnings & Revenue